EFG Asset Management (Americas)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,496
Closed -$240K 131
2023
Q4
$240K Sell
6,496
-1,186
-15% -$44.7K 0.05% 136
2023
Q3
$293K Sell
7,682
-327
-4% -$13.4K 0.07% 127
2023
Q2
$289K Buy
8,009
+1,335
+20% +$45.5K 0.07% 127
2023
Q1
$255K Buy
6,674
+976
+17% +$45.8K 0.06% 129
2022
Q4
$324K Sell
5,698
-1,907
-25% -$97.6K 0.08% 113
2022
Q3
$301K Sell
7,605
-570
-7% -$25.2K 0.08% 116
2022
Q2
$360K Sell
8,175
-6,060
-43% -$262K 0.09% 111
2022
Q1
$568K Buy
14,235
+551
+4% +$19.6K 0.11% 107
2021
Q4
$550K Buy
13,684
+2,726
+25% +$102K 0.09% 115
2021
Q3
$446K Buy
10,958
+1,147
+12% +$48K 0.08% 119
2021
Q2
$446K Buy
9,811
+1,423
+17% +$63K 0.08% 118
2021
Q1
$350K Buy
8,388
+1,545
+23% +$70.5K 0.07% 122
2020
Q4
$292K Buy
+6,843
New +$246K 0.06% 122

Other funds holding HALO

EFG Asset Management (Americas)'s HALO Position: Q1 2024 in Review

EFG Asset Management (Americas) sold out of Halozyme (HALO) in Q1 2024, closing a stake of 6,496 shares — an estimated $240K sold.

EFG Asset Management (Americas) first reported a position in HALO in Q4 2020 and held it in 13 quarters. The position peaked at $568K in Q1 2022. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

  • EFG Asset Management (Americas) reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 6,496 Halozyme shares in Q1 2024, an estimated $240K.
  • EFG Asset Management (Americas) first reported a position in Halozyme in Q4 2020 and held it in 13 quarters.
  • EFG Asset Management (Americas)'s Halozyme position peaked at $568K in Q1 2022.
  • 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on EFG Asset Management (Americas)'s 13F filing for Q1 2024, filed 22 Apr 2024.